Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FKMWN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,644
Award facts
- Contract value 100% obligated
- $8,644.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XOLAIR 150 mg/ml syringes valued at $8,644.08 under a firm fixed-price contract. The award was made on July 29, 2025, with an ultimate completion date of August 19, 2025. This is an unset-aside, competitively awarded delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
XOLAIR (omalizumab) is a specialty biologic medication used to treat moderate-to-severe allergic asthma and other allergic conditions, reflecting the breadth of pharmaceutical products AmerisourceBergen supplies to support military and federal healthcare systems. This delivery order represents a routine fulfillment within AmerisourceBergen's role as a critical pharmaceutical distributor for the Defense Health Agency and other federal healthcare customers. The company's extensive portfolio with DLA includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains, demonstrating its established capability to meet federal procurement requirements for complex medical supply needs.
Quick answers
Who was awarded contract SPE2DB25FKMWN?
SPE2DB25FKMWN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FKMWN worth?
The government has obligated $8,644 on SPE2DB25FKMWN.
Is contract SPE2DB25FKMWN an order under another contract?
Yes. SPE2DB25FKMWN is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKMWN competed?
The extent of competition for SPE2DB25FKMWN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award